106B2.7%
Total Revenue QoQ (NONE) - Q4 '25

Sign up to access historical data

Sign up

Similar companies

Income Statement (NONE)

Q4 '25 QoQ
Revenue 106B 2.7%
Gross Profit 13.6B 1.7%
Cost of Revenue 92.1B 3.4%
Operating expense 11.5B 32.7%
Net Income 2.94B 174%
EBITDA 3.29B 310.2%

Balance Sheet (NONE)

Q4 '25 QoQ
Total Assets 261B 2.2%
Total Liabilities 186B 1.9%
Total Equity 75.2B 3.1%
Shares Outstanding 1.28B 0.6%

Cash Flow (NONE)

Q4 '25 QoQ
Cash from operations 3.39B 325.9%
Cash from investing -2B 4.3%
Cash from financing -2.03B 47%

EPS

Only available for members.

Financial Highlights for CVS Health in Q4 '25

CVS Health reported a revenue of 106B, which is a 2.7% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.

Gross Profit stood at 13.6B, marking a -1.7% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.

Cost of Revenue was 92.1B, a 3.4% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.

Operating Expenses for this period were 11.5B, showing a -32.7% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.

Net Income for the quarter was 2.94B, showing a 174% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.

The company's EBITDA for the quarter was 3.29B, showing a 310.2% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.

CVS Health faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.